Abstract:Keloid is a benign dermal fibrotic disorder with some features similar to malignant tumors such as hyper-proliferation, apoptosis resistance and invasion. keloid remains a therapeutic challenge in terms of high recurrence rate and lack of satisfactory medical therapies, which is partially due to the incomplete understanding of keloid pathogenesis. A thorough understanding of the cellular and molecular mechanism of keloid pathogenesis would facilitate the development of novel medical therapies for this disease. Here, we performed single-cell RNA-seq of 28,064 cells from keloid skin tissue and adjacent relatively normal tissue. Unbiased clustering revealed substantial cellular heterogeneity of the keloid tissue, which included 21 cell clusters assigned to 11 cell lineages. Differential proportion analysis revealed significant expansion for fibroblasts and vascular endothelial cells in keloid compared with control, reflecting their strong association with keloid pathogenesis. We then identified five previously unrecognized subpopulations of keloid fibroblasts and four subpopulations of vascular endothelial cells. Comparative analyses were performed to identify the dysregulated pathways, regulators and ligand-receptor interactions for keloid fibroblasts and vascular endothelial cells, the two important cell lineages in keloid pathogenesis and for medical interventions. Our results highlight the roles of transforming growth factor beta and Eph-ephrin signaling pathways in both the aberrant fibrogenesis and angiogenesis of keloid. Critical regulators and signaling receptors implicated in the fibrogenesis of other fibrotic disorders, such as TWIST1, FOXO3, SMAD3 and EPHB2, ranked at the top in the regulatory network of keloid fibroblasts. In addition, tumor-related pathways such as negative regulation of PTEN transcription were found to be activated in keloid fibroblasts and vascular endothelial cells, which may be responsible for the malignant features of keloid. Our study put novel insights into the pathogenesis of keloid, and provided potential targets for medical therapies. Our dataset also constitutes a valuable resource for further investigations of the mechanism of keloid pathogenesis.

Characterization of the skin keloid microenvironment

Epigenetic modification mechanisms involved in keloid: current status and prospect

Single-Cell RNA-Sequencing Reveals Lineage-Specific Regulatory Changes of Fibroblasts and Vascular Endothelial Cells in Keloids

Exosomes Released by Melanocytes Modulate Fibroblasts to Promote Keloid Formation:A Pilot Study

Single‐cell RNA sequencing highlights the role of proinflammatory fibroblasts, vascular endothelial cells, and immune cells in the keloid immune microenvironment

Keloid Disorder: Genetic Basis, Gene Expression Profiles, and Immunological Modulation of the Fibrotic Processes in the Skin

Progress in the Pathogenesis of Keloids

The effects of systemic diseases, genetic disorders and lifestyle on keloids

Pathological niche environment transforms dermal stem cells to keloid stem cells: a hypothesis of keloid formation and development.

Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseases

Keloidal Pathophysiology: Current Notions.

Research development in the pathogenic mechanism of keloids

Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis

HIF-1α Promotes the Keloid Development Through the Activation of TGF-β/Smad and TLR4/MyD88/NF-κB Pathways.

Revealing the roles of glycosphingolipid metabolism pathway in the development of keloid: a conjoint analysis of single-cell and machine learning

Transcriptome Network Analysis of Inflammation and Fibrosis in Keloids.

Keloid research: current status and future directions

Identification and characterization of four immune-related signatures in keloid

The fibroblast heterogeneity across keloid, normal and tumor samples from single-cell resolution

The Epidemiology of Keloids

Characterization of CD45RO+ Memory T Lymphocytes in Keloid Disease